india_china_credit_pti

China opens market to Indian drugs with reduced tariffs

July 10, 2018
Manufacturing and Production, Sales and Marketing China, India, pharma

India and China have reached an agreement aimed at reducing tariffs on Indian pharmaceuticals going between the world’s two most …

shutterstock_2

EMA issues global recall of heart drugs over cancer risk contamination

July 10, 2018
Manufacturing and Production EMA, Europe, heart disease, pharma, valsartan

Several drugs designed for the treatment of high blood pressure and heart conditions have been recalled across Europe over fears …

sanofihq

Sanofi shut down French plant over “astronomical” emission levels

July 10, 2018
Manufacturing and Production FNE, France, Sanofi, manufacturing, pharma, valproate

Sanofi announced yesterday that they have stopped production at their plant in the French Pyrenees following complaints that the factory …

NICE calls to limit antibiotic use in COPD over antimicrobial resistance fears

July 10, 2018
Manufacturing and Production, Medical Communications, Research and Development COPD, NICE, antimicrobial resistance, chronic obstructive pulmonary disease, pharma

NICE have published a draft antimicrobial prescribing guide recommending that healthcare professionals should consider the risk of antimicrobial resistance when …

donald_trump_september_3_2015

Trump slams Pfizer over price hikes, Pfizer responds

July 10, 2018
Manufacturing and Production, Sales and Marketing Donald Trump, Drug pricing, Pfizer, Trump, pharma

Price hiking in the pharmaceutical industry continues to persist, and has become ever more prominent in the public sphere thanks …

merckincweb2

MSD’s ulcerative colitis drug scores expanded indication in Europe

July 9, 2018
Sales and Marketing Europe, MSD, pharma, ulcerative colitis

New Jersey-based multinational MSD have announced that the European Commission (EC) has approved Simponi (golimumab) for early dose optimisation in …

Eisai and Biogen’s Alzheimer’s drug slows progression in Phase 2 trials

July 9, 2018
Research and Development, Sales and Marketing

The Japan-based Eisai and Massachusetts-based Biogen have announced that experimental drug BAN2401 has demonstrated efficacy in slowing the progression of …

shutterstock_212035546

Extended use of breast cancer drug tamoxifen linked to increased endometrial cancer risk

July 9, 2018
Research and Development, Sales and Marketing Cancer, breast cancer, endometrial cancer, pharma, tamoxifen

New evidence published in the British Journal of Surgery has indicated a troubling link between long-term use of the breast …

Insider Interview: Biosimilars to balance the books

July 9, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mylan, bisoimilars, multiple sclerosis

Jean-Yves Brault, Country Manager at Mylan UK, discusses how biosimilars are going to play an important role in driving down …

Scotland approves first-line treatment for advanced kidney cancer

July 9, 2018
Sales and Marketing Cancer, Scotland, fotivda, rcc, tivozanib

The Scottish Medicines Consortium has approved the use of EUSA Pharma’s Fotivda (tivozanib) as a first-line treatment for people with …

shutterstock_114045100

Regulus cuts workforce by 60%, halts studies in major restructure

July 9, 2018
Sales and Marketing Regulus, pharma

California-based biotech Regulus Therapeutics has announced it is to strip away more than half of its total workforce as part …

sicorbio

Teva to relocate US HQ to New Jersey, affecting over 1,000 jobs

July 6, 2018
Manufacturing and Production, Medical Communications Teva, US, new jersey, pharma, philadelphia

As the Israeli firm presses on with attempts to cut back on costs and streamline operations, Teva has announced plans …

michel_porro-getty_images

Zynerba’s cannabis-based transdermal patch fails at Phase 1, shares slide 21%

July 6, 2018
Medical Communications, Research and Development GW Pharma, Zynerba, cannabidinol, cannabinol, cannabis, pharma, trial failure

As public focus on the issue of medicinal cannabis continues to grow, Zynerba Pharmaceuticals has announced that its transdermal tetrahydrocannabinol …

Missouri appeals court overturns $55m J&J verdict

July 6, 2018
Medical Communications, Sales and Marketing Cancer, J&J, JJ, Litigation, appeal, pharma

A $55 million verdict against the multinational pharmaceutical company Johnson & Johnson has been overturned by an appeals court in …

Toronto, Ontario skyline

Illegally manufactured fentanyl drives deaths in Ontario

July 5, 2018
Medical Communications Crisis, Ontario, canda, epidemic, fentanyl, opioid

Illicit forms of the powerful opioid fentanyl have been driving increased rates of opioid-related deaths in the Canadian province of …

shutterstock_gonnorrhea

Ipsen reveals positive Phase 3 data of Cabometyx in liver cancer

July 5, 2018
Research and Development Cabometyx, Cancer, ipsen, liver cancer, pharma

French pharmaceutical company Ipsen has announced that The New England Journal of Medicine has published the results of a Phase …

kymriah

CHMP recommends Novartis’ CAR-T therapy Kymriah for EU approval

July 5, 2018
Sales and Marketing CAR-T, CHMP, EMA, EU, Kymriah, Novartis, pharma

The Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Medicines Agency (EMA) approve Novartis’ CAR-T …

Cow in field

Global animal health market set to be worth $44.2 billion by 2020

July 5, 2018
Manufacturing and Production, Sales and Marketing Antibiotics, agriculture, animal, health, meat, pharma

The global animal health market is predicted to reach a value of $44.2 billion dollars by 2020, according to analysts …

takeda_usa_pharmaceuticals_u

Takeda to sell Osaka site to soften Shire deal’s financial impact

July 5, 2018
Manufacturing and Production, Sales and Marketing Japan, Osaka, Shire, Takeda, acquisition, pharma

It’s one of the biggest acquisitions the industry has seen at a total value of $63 billion and after weeks …

The Gateway to Local Adoption Series

Latest content